NCAM1 and neoplasm: The expression of 127aa could result in different levels of metabolic excretion in tumor cells, followed by stepwise changes in metabolic pathways in NK cells and, in turn, NK dysfunction, as shown by the decreases in CD56, IFNγ, and GZMB expression.